Workflow
Cvicse Middleware(688695)
icon
Search documents
中创股份(688695) - 山东中创软件商用中间件股份有限公司第七届监事会第十次会议决议公告
2025-04-27 08:30
(一)审议通过《关于公司<2024 年年度报告>及其摘要的议案》 公司监事会认为:公司 2024 年年度报告的编制和审议程序规范合法,内容 符合相关法律、法规、《公司章程》及中国证监会和上海证券交易所的相关规定, 所披露的信息真实、准确、完整,不存在虚假记载、误导性陈述或重大遗漏;不 存在公司参与年报编制和审议的人员违反保密规定的行为。 表决结果:3 票同意,0 票反对,0 票弃权。 该议案尚需提交公司 2024 年年度股东大会审议。 证券代码:688695 证券简称:中创股份 公告编号:2025-006 山东中创软件商用中间件股份有限公司 第七届监事会第十次会议决议公告 本公司监事会及全体监事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏,并对其内容的真实性、准确性和完整性依法承担法律责任。 一、 监事会会议召开情况 山东中创软件商用中间件股份有限公司(以下简称"公司")于 2025 年 4 月 14 日以专人送出方式发出第七届监事会第十次会议通知,本次监事会于 2025 年 4 月 24 日在公司会议室以现场方式召开。会议由监事会主席陈曦女士召集和 主持,会议应出席监事 3 人,实际出席监事 ...
中创股份(688695) - 山东中创软件商用中间件股份有限公司第七届董事会第十次会议决议公告
2025-04-27 08:30
证券代码:688695 证券简称:中创股份 公告编号:2025-005 山东中创软件商用中间件股份有限公司 第七届董事会第十次会议决议公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏,并对其内容的真实性、准确性和完整性依法承担法律责任。 一、 董事会会议召开情况 山东中创软件商用中间件股份有限公司(以下简称"公司")第七届董事会 第十次会议于 2025 年 4 月 24 日在公司会议室以现场结合通讯的方式召开。会议 通知已于 2025 年 4 月 14 日通过专人送出及电话方式送达各位董事。会议由董事 长景新海先生召集和主持,会议应出席董事 5 人,实际出席董事 5 人,公司监事 及高级管理人员列席了会议。本次会议的召集和召开符合《中华人民共和国公司 法》《中华人民共和国证券法》等相关法律法规、规章和规范性文件及《公司章 程》的有关规定,会议决议合法有效。 二、 董事会会议审议情况 (一)审议通过《关于公司<2024 年年度报告>及其摘要的议案》 本议案已经公司第七届董事会审计委员会第九次会议审议通过,尚需提交公 司 2024 年年度股东大会审议。 表决结果:5 票同意; ...
中创股份(688695) - 2025 Q1 - 季度财报
2025-04-27 08:30
Financial Performance - The company's operating revenue for Q1 2025 was ¥32,018,516.83, representing a 12.23% increase compared to ¥28,528,402.44 in the same period last year[4] - The net profit attributable to shareholders was a loss of ¥1,743,729.32, a decrease of 176.91% from a profit of ¥2,267,336.51 in the previous year[4] - Basic and diluted earnings per share were both -¥0.02, a decrease of 150.00% from ¥0.04 in the previous year[4] - Total operating revenue for Q1 2025 reached ¥32,018,516.83, an increase of 12.4% compared to ¥28,528,402.44 in Q1 2024[17] - Total operating costs for Q1 2025 were ¥39,165,477.41, up 20.7% from ¥32,416,937.26 in Q1 2024[17] - Net profit for Q1 2025 was a loss of ¥1,743,729.32, contrasting with a net profit of ¥2,267,336.51 in Q1 2024[19] - The basic and diluted earnings per share for Q1 2025 were both -¥0.02, compared to ¥0.04 in Q1 2024[19] Research and Development - The total R&D investment amounted to ¥18,953,310.84, which is a 58.62% increase from ¥11,948,567.43 in the same period last year[5] - R&D expenses accounted for 59.19% of operating revenue, up by 17.31 percentage points from 41.88% in the previous year[5] - R&D expenses increased significantly to ¥18,953,310.84 in Q1 2025, compared to ¥11,948,567.43 in Q1 2024, reflecting a growth of 58.7%[18] Cash Flow and Liquidity - The net cash flow from operating activities was a negative ¥16,400,388.27, an improvement from a negative ¥29,407,202.32 in the same period last year[4] - Cash inflow from investment activities in Q1 2025 was ¥155,863,666.58, with a net cash flow of ¥83,665,836.78 after outflows[21] - The company reported cash and cash equivalents of ¥415,900,209.48 as of March 31, 2025, an increase from ¥358,161,119.60 on December 31, 2024, reflecting a growth of approximately 16.3%[13] - The net increase in cash and cash equivalents for the period was $57,807,689.88, compared to $373,468,830.11 in the previous period[23] - The ending balance of cash and cash equivalents was $344,433,799.48, up from $567,541,468.11 in the previous period[23] - The beginning balance of cash and cash equivalents was $286,626,109.60, indicating a strong liquidity position[23] Assets and Liabilities - The total assets at the end of the reporting period were ¥841,321,928.61, a decrease of 2.17% from ¥859,989,449.60 at the end of the previous year[5] - Total assets decreased to ¥841,321,928.61 from ¥859,989,449.60, indicating a decline of approximately 2.2%[14] - Current liabilities decreased significantly from ¥45,265,467.33 to ¥27,765,394.67, a reduction of about 38.6%[14] - The company’s non-current assets increased to ¥86,990,980.30 from ¥84,372,249.32, representing a growth of approximately 3.8%[14] - The company reported a total liability of ¥31,747,293.00, down from ¥48,671,084.67 in the previous period[15] - Total equity attributable to shareholders was ¥809,574,635.61, slightly down from ¥811,318,364.93[15] Shareholder Information - The total number of ordinary shareholders at the end of the reporting period was 5,440[9] - The company’s total equity remains stable, with no significant changes reported in the equity section of the balance sheet[14] Strategic Outlook - The company plans to continue expanding its market share and enhancing product competitiveness through increased sales and R&D expenditures[7] - The company has not disclosed any new product developments or market expansion strategies during the reporting period[12]
中创股份(688695) - 2024 Q4 - 年度财报
2025-04-27 08:30
Financial Performance - The company's operating revenue for 2024 was CNY 194,253,698.38, representing a 7.96% increase compared to CNY 179,927,539.64 in 2023[24]. - The net profit attributable to shareholders for 2024 decreased by 41.92% to CNY 38,716,796.74 from CNY 66,663,365.22 in 2023[24]. - The net cash flow from operating activities for 2024 was negative at CNY -16,798,090.71, a decrease of 265.56% compared to CNY 10,145,927.12 in 2023[24]. - The company's total assets increased by 90.32% to CNY 859,989,449.60 in 2024 from CNY 451,864,879.78 in 2023[24]. - The net assets attributable to shareholders rose by 106.10% to CNY 811,318,364.93 in 2024 from CNY 393,656,570.31 in 2023[24]. - Basic earnings per share for 2024 were CNY 0.49, down 53.33% from CNY 1.05 in 2023[25]. - The proportion of R&D investment to operating revenue increased by 5.75 percentage points to 29.04% in 2024 from 23.29% in 2023[25]. - The weighted average return on net assets decreased by 12.99 percentage points to 5.51% in 2024 from 18.50% in 2023[25]. - The net profit after deducting non-recurring gains and losses for 2024 was CNY 35,794,595.86, a decrease of 43.36% from CNY 63,194,917.39 in 2023[24]. - The company achieved a net profit attributable to shareholders of 38.72 million yuan, a decrease of 41.92% year-on-year, and a net profit after deducting non-recurring gains and losses of 35.79 million yuan, down 43.36% year-on-year[26]. Dividend Distribution - The company plans to distribute a cash dividend of 1.40 RMB per 10 shares, totaling approximately 11.91 million RMB, which represents 30.75% of the net profit attributable to shareholders for the year[7]. - The company distributed a cash dividend of 2.40 yuan per 10 shares for the 2023 fiscal year, amounting to 20,412,330.72 yuan, which is 30.62% of the net profit attributable to shareholders[169]. - The cash dividend amount (including tax) is RMB 11,907,192.92, which accounts for 30.75% of the net profit attributable to ordinary shareholders[174]. - The cumulative cash dividend amount over the last three fiscal years is RMB 11,907,192.92, with an average annual net profit of RMB 38,716,796.74, resulting in a cash dividend ratio of 30.75%[176]. Research and Development - The company achieved a total R&D investment of ¥56,408,648.13, representing a year-on-year increase of 34.61%[65]. - R&D investment accounted for 29.04% of total revenue, an increase of 5.75 percentage points compared to the previous year[65]. - The company filed 42 new invention patent applications and 35 software copyright applications during the reporting period, and obtained 5 new invention patents and 30 software copyrights, enhancing its intellectual property portfolio[37]. - The company has accumulated a total of 156 invention patents and 235 software copyrights, demonstrating its strong R&D capabilities and breaking the technological monopoly of major foreign middleware vendors like IBM and Oracle[39]. - The company is committed to technological innovation and has increased investment in R&D to enhance its core product competitiveness[26]. Market Expansion and Strategy - The company is focusing on market expansion and enhancing brand influence by increasing marketing efforts and broadening sales channels in key regions and industries[34]. - The domestic middleware market is experiencing significant growth driven by national policies and the digital economy, creating new market opportunities for the company[34]. - The company is actively pursuing research and development in new technologies to enhance its competitive edge in various industries, including finance and healthcare[70]. - The company is expanding its market presence by integrating domestic foundational software solutions to support application system construction[71]. - The company aims to improve user experience and problem diagnosis capabilities during operation and maintenance processes, enhancing overall service quality[71]. Compliance and Governance - The company has established a comprehensive governance structure, including a shareholders' meeting, board of directors, supervisory board, and management team, ensuring clear responsibilities and effective operations[136]. - The board of directors consists of 5 members, including 2 independent directors, and has held 7 meetings during the reporting period, ensuring compliance with legal requirements[137]. - The supervisory board has 3 members and conducted 7 meetings, effectively overseeing the company's operations and protecting shareholder rights[138]. - The company adheres to strict information disclosure practices, ensuring timely and accurate communication with shareholders[140]. - The company has established a comprehensive internal control system in compliance with relevant laws and regulations, ensuring standardized operations[179]. Environmental and Social Responsibility - The company emphasizes ESG management, integrating sustainable development into its operations and actively fulfilling social responsibilities[182]. - The company does not engage in production activities and is not classified as a key pollutant discharge unit by environmental protection authorities[187]. - The company has established a series of environmental protection management systems, including waste management and energy conservation measures, in compliance with ISO14001 standards[189]. - The company emphasizes sustainable development and has implemented measures such as promoting green commuting and paperless offices to reduce carbon emissions[190]. Talent Development and Employee Relations - The company has established a comprehensive performance evaluation and incentive mechanism to ensure competitive salary levels and promote mutual growth with employees[166]. - The company has focused on training programs to enhance employee skills in line with industry trends, including courses on artificial intelligence and big data analysis[167]. - The total remuneration for core technical personnel at the end of the reporting period amounted to 2.7498 million RMB[153]. - The company has maintained good communication with investors through performance briefings and various engagement methods to protect shareholder rights[195]. - The company strictly adheres to labor laws and provides various employee benefits, including health check-ups and free meals, to ensure employee rights[196].
中创股份(688695) - 山东中创软件商用中间件股份有限公司关于2024年度利润分配预案的公告
2025-04-27 08:30
证券代码:688695 证券简称:中创股份 公告编号:2025-007 山东中创软件商用中间件股份有限公司 关于 2024 年度利润分配预案的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏,并对其内容的真实性、准确性和完整性依法承担法律责任。 重要内容提示: 每股分配比例:A 股每股派发现金红利 0.14 元(含税),不进行资本公 积金转增股本,不送红股。 本次利润分配以实施权益分派股权登记日登记的总股本为基数,具体日 期将在权益分派实施公告中明确。 一、利润分配预案内容 在实施权益分派的股权登记日前公司总股本发生变动的,公司拟维持每 股分配比例不变,相应调整分配总额。如后续总股本发生变化,公司将另行公告 具体调整情况。 公司 2024 年度利润分配预案已经公司第七届董事会第十次会议及第七 届监事会第十次会议审议通过,尚需提交公司 2024 年年度股东大会审议。 本次利润分配预案不触及《上海证券交易所科创板股票上市规则》第 12.9.1 条第一款第(八)项规定的可能被实施其他风险警示的情形。 (一)利润分配预案的具体内容 经致同会计师事务所(特殊普通合伙)审计,截至 2 ...
中创股份(688695) - 开源证券股份有限公司、民生证券股份有限公司关于山东中创软件商用中间件股份有限公司2024年度募集资金存放与实际使用情况的专项核查意见
2025-04-27 08:26
开源证券股份有限公司、民生证券股份有限公司 关于山东中创软件商用中间件股份有限公司 2024 年度募集资金存放与实际使用情况的专项核查报告 开源证券股份有限公司、民生证券股份有限公司作为山东中创软件商用中间 件股份有限公司(以下简称"中创股份""公司")首次公开股票并在科创板上市 的保荐机构,根据《证券发行上市保荐业务管理办法》《上海证券交易所科创板 股票上市规则》和《上海证券交易所上市公司自律监管指引第 1 号——规范运作》 等相关规定,对中创股份 2024 年度募集资金存放与实际使用情况进行了核查, 并发表核查意见如下: 一、募集资金基本情况 (一)实际募集资金金额和资金到账时间 根据中国证券监督管理委员会于 2023 年 5 月 11 日出具的《关于同意山东中 创软件商用中间件股份有限公司首次公开发行股票注册的批复》(证监许可 〔2023〕1066 号),公司获准向社会公开发行人民币普通股(A 股)2,126.2845 万股,每股发行价格为人民币 22.43 元,募集资金总额为 47,692.56 万元;扣除 各项发行费用(不含增值税金额)共计 7,756.83 万元后,募集资金净额为 39,935.7 ...
中创股份(688695) - 开源证券股份有限公司、民生证券股份有限公司关于山东中创软件商用中间件股份有限公司2024年度持续督导跟踪报告
2025-04-27 08:26
开源证券股份有限公司、民生证券股份有限公司 关于山东中创软件商用中间件股份有限公司 2024 年度持续督导跟踪报告 开源证券股份有限公司、民生证券股份有限公司(以下简称"保荐机构""保 荐人")作为山东中创软件商用中间件股份有限公司(以下简称"中创股份""上 市公司""公司")首次公开发行股票并在科创板上市的保荐机构,根据《证券发 行上市保荐业务管理办法》《上海证券交易所科创板股票上市规则》和《上海证 券交易所上市公司自律监管指引第 11 号——持续督导》等相关规定,负责中创 股份上市后的持续督导工作,并出具 2024 年度持续督导跟踪报告。 2024 年度,保荐机构对中创股份的持续督导情况工作总结如下: | 序号 | 工作内容 | 实施情况 | | --- | --- | --- | | 1 | 建立健全并有效执行持续督导工作制 度,并针对具体的持续督导工作制定相 | 保荐机构已经建立健全并有效执行了持 | | | | 续督导制度,并制定了相应的工作计划 | | | 应的工作计划 | | | | 根据中国证监会相关规定,在持续督导 工作开始前,与上市公司或相关当事人 签署持续督导协议,明确双方在持续督 | ...
中创股份(688695) - 山东中创软件商用中间件股份有限公司2024年度内部控制审计报告
2025-04-27 08:26
致同会计师事务所 (特殊普通合伙) ornton 司会计师 各所(禁 内部控制审计报告 山东中创软件商用中间件股份有限公司 二〇二四年度 内部控制审计报告 致同审字(2025)第 371A018200 号 山东中创软件商用中间件股份有限公司全体股东: 按照《企业内部控制审计指引》及中国注册会计师执业准则的相关要求, 我们审计了山东中创软件商用中间件股份有限公司(以下简称中创股份公司) 2024年 12月 31日的财务报告内部控制的有效性。 一、企业对内部控制的责任 按照《企业内部控制基本规范》、《企业内部控制应用指引》、《企业 内部控制评价指引》的规定,建立健全和有效实施内部控制,并评价其有效 性是中创股份公司董事会的责任。 二、注册会计师的责任 我们的责任是在实施审计工作的基础上,对财务报告内部控制的有效性 发表审计意见,并对注意到的非财务报告内部控制的重大缺陷进行披露。 三、内部控制的固有局限性 内部控制具有固有局限性,存在不能防止和发现错报的可能性。此外, 由于情况的变化可能导致内部控制变得不恰当,或对控制政策和程序遵循的 程度降低,根据内部控制审计结果推测未来内部控制的有效性具有一定风险。 Grant ...
中创股份(688695) - 致同会计师事务所(特殊普通合伙)关于山东中创软件商用中间件股份有限公司非经营性资金占用及其他关联资金往来情况汇总表的专项审计报告
2025-04-27 08:26
关于山东中创软件商用中间件股份有限公司 非经营性资金占用及其他关联资金往来情况 汇总表的专项审计报告 审计单位:致同会计师事务所(特殊普通合伙) 联系电话:+86 10 8566 5588 盟可提现"扫一扫"成进入"注意会计师行全线一直营平台【hqv//www.gmol "三门户 "国计处刑手机"扫一扫"成进入"注意会计师行全线一直营平台【hqv//www.gxmall "三门户 1、 专项审计报告 2、 附表 关于山东中创软件商用中间件 股份有限公司 非经营性资金占用及其他关联 资金往来的专项说明 致同会计师事务所(特殊普通合伙) 目 录 委托单位:关于山东中创软件商用中间件股份有限公司 目 录 关于山东中创软件商用中同件股份有限公司非经营企占用及 其他关联资会往来的专项说明 关于山东中创软件离用中间件股份有限公司 非经营性资金占用及其他关联资金往来的专项说明 致目专字(2025)第 371AD10736号 山东中创软件商用中同件股份有限公司全体股东: 我们接受山东中创软件筒用中间件般份有限公司(以下简称"中创股份 公司")委托,根据中国注册会计师执业准则审计了中创股份公司 2024年 12 月 31 日的 ...
中创股份(688695) - 开源证券股份有限公司、民生证券股份有限公司关于山东中创软件商用中间件股份有限公司使用闲置募集资金进行现金管理的核查意见
2025-04-27 08:26
开源证券股份有限公司、民生证券股份有限公司 关于山东中创软件商用中间件股份有限公司 使用闲置募集资金进行现金管理的核查意见 开源证券股份有限公司和民生证券股份有限公司作为山东中创软件商用中 间件股份有限公司(以下简称"中创股份""公司")首次公开发行股票并在科创 板上市的保荐机构,根据《证券发行上市保荐业务管理办法》《上海证券交易所 科创板股票上市规则》《上海证券交易所科创板上市公司自律监管指引第 1 号— —规范运作》及《上市公司监管指引第 2 号——上市公司募集资金管理和使用的 监管要求》等规定,对中创股份使用闲置募集资金进行现金管理事项进行了核查, 核查情况及核查意见如下: 一、募集资金基本情况 根据中国证券监督管理委员会于 2023 年 5 月 11 日出具的《关于同意山东中 创软件商用中间件股份有限公司首次公开发行股票注册的批复》(证监许可 〔2023〕1066 号),公司获准向社会公开发行人民币普通股(A 股)2,126.2845 万股,每股发行价格为人民币 22.43 元,募集资金总额为 47,692.56 万元;扣除 各项发行费用(不含增值税金额)共计 7,756.83 万元后,募集资金净额为 ...